NC5

3-[(2R)-2-ethylpiperidin-1-yl]-N-[6-({3-[(2S)-2-ethylpiperidin-1-yl]propanoyl}amino)acridin-3-yl]propanamide

Created:	2008-10-13
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where NC5 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	85
Chiral Atom Count	2
Bond Count	89
Aromatic Bond Count	16

2D diagram of NC5

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	3-[(2R)-2-ethylpiperidin-1-yl]-N-[6-({3-[(2S)-2-ethylpiperidin-1-yl]propanoyl}amino)acridin-3-yl]propanamide
Systematic Name (OpenEye OEToolkits)	3-[(1S,2S)-2-ethylpiperidin-1-yl]-N-[6-[3-[(1S,2S)-2-ethylpiperidin-1-yl]propanoylamino]acridin-3-yl]propanamide
Formula	C₃₃ H₄₅ N₅ O₂
Molecular Weight	543.743
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(Nc3cc2nc1cc(ccc1cc2cc3)NC(=O)CCN4C(CCCC4)CC)CCN5C(CC)CCCC5
SMILES	CACTVS	3.341	CC[CH]1CCCCN1CCC(=O)Nc2ccc3cc4ccc(NC(=O)CCN5CCCC[CH]5CC)cc4nc3c2
SMILES	OpenEye OEToolkits	1.5.0	CCC1CCCCN1CCC(=O)Nc2ccc3cc4ccc(cc4nc3c2)NC(=O)CCN5CCCCC5CC
Canonical SMILES	CACTVS	3.341	CC[C@@H]1CCCCN1CCC(=O)Nc2ccc3cc4ccc(NC(=O)CCN5CCCC[C@@H]5CC)cc4nc3c2
Canonical SMILES	OpenEye OEToolkits	1.5.0	CC[C@@H]1CCCC[N@]1CCC(=O)Nc2ccc3cc4ccc(cc4nc3c2)NC(=O)CC[N@@]5CCCC[C@@H]5CC
InChI	InChI	1.03	InChI=1S/C33H45N5O2/c1-3-28-9-5-7-17-37(28)19-15-32(39)34-26-13-11-24-21-25-12-14-27(23-31(25)36-30(24)22-26)35-33(40)16-20-38-18-8-6-10-29(38)4-2/h11-14,21-23,28-29H,3-10,15-20H2,1-2H3,(H,34,39)(H,35,40)/t28-,29+
InChIKey	InChI	1.03	ZWPUGYBFVBXUSX-ISILISOKSA-N

Related Resource References

Resource Name	Reference
PubChem	25113176

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.